{"id":"https://openalex.org/W2023398587","doi":"https://doi.org/10.1021/jm9801253","title":"Inhibition of in Vitro and in Vivo HIV Replication by a Distamycin Analogue That Interferes with Chemokine Receptor Function: A Candidate for Chemotherapeutic and Microbicidal Application","display_name":"Inhibition of in Vitro and in Vivo HIV Replication by a Distamycin Analogue That Interferes with Chemokine Receptor Function: A Candidate for Chemotherapeutic and Microbicidal Application","publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W2023398587","doi":"https://doi.org/10.1021/jm9801253","mag":"2023398587","pmid":"https://pubmed.ncbi.nlm.nih.gov/9632350"},"language":"en","primary_location":{"id":"doi:10.1021/jm9801253","doi":"https://doi.org/10.1021/jm9801253","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm9801253","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067466991","display_name":"O. M. Zack Howard","orcid":"https://orcid.org/0000-0002-0505-7052","observed_orcids":["https://orcid.org/0000-0002-0505-7052"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. M. Z. Howard","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042240287","display_name":"Joost J. Oppenheim","orcid":"https://orcid.org/0000-0003-0271-7921","observed_orcids":["https://orcid.org/0000-0003-0271-7921"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. J. Oppenheim","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080778766","display_name":"Melinda G. Hollingshead","orcid":"https://orcid.org/0000-0002-1207-1397","observed_orcids":["https://orcid.org/0000-0002-1207-1397"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda G. Hollingshead","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034690406","display_name":"Joseph M. Covey","orcid":"https://orcid.org/0000-0002-5696-8999","observed_orcids":["https://orcid.org/0000-0002-5696-8999"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Covey","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113725441","display_name":"James C. Bigelow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Bigelow","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. J. McCormack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. J. McCormack","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert W. Buckheit,","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert W. Buckheit,","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069492078","display_name":"David J. Clanton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Clanton","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081253935","display_name":"Jim A. Turpin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim A. Turpin","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024503165","display_name":"William G. Rice","orcid":"https://orcid.org/0000-0001-5705-9474","observed_orcids":["https://orcid.org/0000-0001-5705-9474"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Rice","raw_affiliation_strings":["Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Support Program, Anti-AIDS Virus Drug Screening Laboratory, and Laboratory of Antiviral Drug Mechanisms, SAIC Frederick, and Laboratory of Molecular Immunoregulation, Division of Basic Science, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, Department of Pharmacology and Vermont Cancer Center,","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.0927,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.94324077,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"41","issue":"13","first_page":"2184","last_page":"2193"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.4982999861240387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.4982999861240387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.27320000529289246,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.21480000019073486,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/distamycin-analogues","display_name":"distamycin analogues","score":0.972000002861023},{"id":"https://openalex.org/keywords/hiv-1-replication-inhibition","display_name":"HIV-1 replication inhibition","score":0.8569999933242798},{"id":"https://openalex.org/keywords/chemokine-receptors","display_name":"chemokine receptors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/ccr5","display_name":"CCR5","score":0.9010000228881836},{"id":"https://openalex.org/keywords/ccr3","display_name":"CCR3","score":0.8679999709129333},{"id":"https://openalex.org/keywords/ccr1","display_name":"CCR1","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cxcr4","display_name":"CXCR4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hiv-coreceptor","display_name":"HIV co-receptor","score":0.6330000162124634},{"id":"https://openalex.org/keywords/calcium-flux","display_name":"calcium flux","score":0.7329999804496765},{"id":"https://openalex.org/keywords/hiv-2","display_name":"HIV-2","score":0.7990000247955322},{"id":"https://openalex.org/keywords/simian-immunodeficiency-virus","display_name":"simian immunodeficiency virus","score":0.9309999942779541},{"id":"https://openalex.org/keywords/microbicides","display_name":"microbicides","score":0.7200000286102295},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.6069999933242798},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.7179617881774902},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6966530680656433},{"id":"https://openalex.org/C84913492","wikidata":"https://www.wikidata.org/wiki/Q5014892","display_name":"CXC chemokine receptors","level":5,"score":0.6386748552322388},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6177207231521606},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5963945388793945},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5426708459854126},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5418480634689331},{"id":"https://openalex.org/C45635710","wikidata":"https://www.wikidata.org/wiki/Q418404","display_name":"Chemokine receptor CCR5","level":5,"score":0.4930841624736786},{"id":"https://openalex.org/C129470790","wikidata":"https://www.wikidata.org/wiki/Q415718","display_name":"CXCR4","level":4,"score":0.469601035118103},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41634005308151245},{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.41381117701530457},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38633424043655396},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3259388208389282},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28499850630760193},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008561","descriptor_name":"Membrane Fusion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009282","descriptor_name":"Naphthalenesulfonates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009282","descriptor_name":"Naphthalenesulfonates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009282","descriptor_name":"Naphthalenesulfonates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009282","descriptor_name":"Naphthalenesulfonates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015302","descriptor_name":"Simian Immunodeficiency Virus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015302","descriptor_name":"Simian Immunodeficiency Virus","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019281","descriptor_name":"Dimerization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019707","descriptor_name":"Receptors, Chemokine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019718","descriptor_name":"Receptors, CXCR4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019718","descriptor_name":"Receptors, CXCR4","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm9801253","doi":"https://doi.org/10.1021/jm9801253","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm9801253","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:9632350","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9632350","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W82820957","https://openalex.org/W138492706","https://openalex.org/W1555396376","https://openalex.org/W1963934971","https://openalex.org/W1963984954","https://openalex.org/W1965019797","https://openalex.org/W1971777539","https://openalex.org/W1980862600","https://openalex.org/W1990722970","https://openalex.org/W2007021820","https://openalex.org/W2008130406","https://openalex.org/W2009324334","https://openalex.org/W2026330341","https://openalex.org/W2029402031","https://openalex.org/W2041573061","https://openalex.org/W2051377225","https://openalex.org/W2052392655","https://openalex.org/W2062148688","https://openalex.org/W2067701958","https://openalex.org/W2067964854","https://openalex.org/W2069353852","https://openalex.org/W2073863059","https://openalex.org/W2078778857","https://openalex.org/W2117394497","https://openalex.org/W2131350942","https://openalex.org/W2131376910","https://openalex.org/W2142655367","https://openalex.org/W2150898533","https://openalex.org/W2158294445","https://openalex.org/W2327227017"],"related_works":["https://openalex.org/W2123961122","https://openalex.org/W2161416666","https://openalex.org/W1995980722","https://openalex.org/W2023329302","https://openalex.org/W2917452284","https://openalex.org/W2046059891","https://openalex.org/W2017977773","https://openalex.org/W2416182844","https://openalex.org/W1965485473","https://openalex.org/W2171588267"],"abstract_inverted_index":{"Select":[0],"chemokine":[1,37,159],"receptors":[2],"act":[3],"as":[4,107,109,183,198],"coreceptors":[5,160],"for":[6,15,75,87,175,201],"HIV-1":[7,105,152,180],"entry":[8,153],"into":[9,154],"human":[10],"cells":[11,155],"and":[12,43,51,111,113,131,133,182],"represent":[13],"targets":[14],"antiviral":[16],"therapy.":[17,168],"In":[18,123],"this":[19],"report":[20],"we":[21],"describe":[22],"a":[23,72,101,120,125,163,184,199],"distamycin":[24,126],"analogue,":[25],"2,2'-[4,":[26],"4'-[[aminocarbonyl]amino]bis[N,4'-di[pryrrole-2-carboxamide-":[27],"1,":[28],"1'-dimethyl]]-6,8-naphthalenedisulfonic":[29],"acid]hexasodium":[30],"salt":[31],"(NSC":[32],"651016),":[33],"that":[34,147],"selectively":[35],"inhibited":[36,96],"binding":[38],"to":[39,47,60,166,186,206],"CCR5,":[40],"CCR3,":[41],"CCR1,":[42],"CXCR4,":[44],"but":[45,68,89],"not":[46,58,90],"CXCR2":[48],"or":[49],"CCR2b,":[50],"blocked":[52],"chemokine-induced":[53],"calcium":[54],"flux.":[55],"Inhibition":[56],"was":[57,69,85],"due":[59],"nonspecific":[61],"charge":[62,132],"interactions":[63],"at":[64],"the":[65,76,82,134,176,188],"cell":[66],"surface,":[67],"based":[70],"on":[71],"specific":[73,86,158],"competition":[74],"ligand":[77],"receptor":[78],"interaction":[79],"sites":[80],"since":[81],"inhibitory":[83,142],"effect":[84],"some":[88],"all":[91],"chemoattractant":[92],"receptors.":[93],"NSC":[94,138,169,194],"651016":[95,139,170,195],"in":[97,115,119],"vitro":[98],"replication":[99],"of":[100,104,137,179,191],"wide":[102],"range":[103],"isolates,":[106],"well":[108],"HIV-2":[110],"SIV,":[112],"exhibited":[114],"vivo":[116],"anti-HIV-1":[117,167],"activity":[118],"murine":[121],"model.":[122],"contrast,":[124],"analogue":[127],"with":[128,151],"similar":[129],"structure":[130],"monomeric":[135],"form":[136],"demonstrated":[140],"no":[141],"effects.":[143],"These":[144],"data":[145],"demonstrate":[146],"molecules":[148],"which":[149],"interfere":[150],"by":[156],"targeting":[157],"can":[161,196],"provide":[162],"viable":[164],"approach":[165],"represents":[171],"an":[172],"attractive":[173],"candidate":[174],"chemotherapeutic":[177],"treatment":[178],"infection":[181],"microbicide":[185],"prevent":[187],"sexual":[189],"transmisssion":[190],"HIV-1.":[192],"Moreover,":[193],"serve":[197],"template":[200],"medicinal":[202],"chemical":[203],"modifications":[204],"leading":[205],"more":[207],"effective":[208],"antivirals.":[209]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}